Effects of anti–TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease
Authors:
- Alfredo J LucendoAlfredo J Lucendo
- Miriam- Ruiz- PonceMPMiriam- Ruiz- Ponce
- Emilio Laserna-MendietaELEmilio Laserna-Mendieta
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 52 (4) , 400-407
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III
- European Social Fund Plus (2014-2020)
This publication has 42 references indexed in Scilit:
- The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisRheumatology, 2013
- Serum hepcidin and prohepcidin concentrations in inflammatory bowel diseaseEuropean Journal of Gastroenterology & Hepatology, 2011
- Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvementInflammatory Bowel Diseases, 2009
- Myelodysplasia and anemia of chronic disease in human tumor necrosis factor‐α transgenic miceCytometry Part A, 2008
- Impaired intestinal iron absorption in Crohnʼs disease correlates with disease activity and markers of inflammationInflammatory Bowel Diseases, 2006
- Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patientsInflammatory Bowel Diseases, 2006
- Economic Burden of Patients with Anemia in Selected DiseasesValue in Health, 2005
- Anemia of Chronic DiseaseNew England Journal of Medicine, 2005
- Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammationBlood, 2003
- Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti–tumor necrosis factor-α antibody therapyBlood, 2002